Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Medicinova Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 23 | 26 | +3 |
| Shares | 5.17M | 5.13M | −42.8K (−0.8%) |
| Value | $6.77M | $6.49M | −$286.0K (−4.2%) |
New holders (4)
Institutions that held Medicinova Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 72,897 | $91.8K | 0.00% |
| Morgan Stanley | 2,000 | $2.54K | 0.00% |
| FMR LLC | 50 | $63 | 0.00% |
| Royal Bank of Canada | 6 | $0 | 0.00% |
Sold out (1)
Institutions that held Medicinova Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| BNP Paribas Arbitrage, SA | 412 | $540 |